Participants who developed AD or aMCI were older, less educated, had a higher prevalence of non-amnestic MCI at baseline, and had higher IL-6 PRS scores at 7 out of 10 GWAS significance thresholds, compared to those who remained AD/aMCI-free. The gene discussed is IL6; the disease is Alzheimer disease.